Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Assets Average: 2011-2025

Historic Assets Average for OptimizeRx (OPRX) over the last 15 years, with Q3 2025 value amounting to $676.0 million.

  • OptimizeRx's Assets Average fell 18.02% to $676.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $676.0 million, marking a year-over-year decrease of 18.02%. This contributed to the annual value of $177.3 million for FY2024, which is 1148.24% up from last year.
  • Latest data reveals that OptimizeRx reported Assets Average of $676.0 million as of Q3 2025, which was down 18.02% from $675.2 million recorded in Q2 2025.
  • In the past 5 years, OptimizeRx's Assets Average ranged from a high of $691.7 million in Q4 2024 and a low of $263.4 million during Q1 2021
  • Its 5-year average for Assets Average is $551.7 million, with a median of $553.3 million in 2022.
  • In the last 5 years, OptimizeRx's Assets Average soared by 11888.18% in 2021 and then plummeted by 787.86% in 2023.
  • OptimizeRx's Assets Average (Quarter) stood at $494.5 million in 2021, then rose by 13.1% to $559.3 million in 2022, then decreased by 4.17% to $536.0 million in 2023, then increased by 29.06% to $691.7 million in 2024, then dropped by 2.28% to $676.0 million in 2025.
  • Its last three reported values are $676.0 million in Q3 2025, $675.2 million for Q2 2025, and $681.3 million during Q1 2025.